drug · oligonucleotide
patient view →inclisiran
Marketedupdated 2mo agoby $NVS NOVARTIS AG🔗 ChEMBL
Approvedcommunity read0 votes
Oligonucleotide drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 6 investigational indications.
indications
investigational
Hyperlipidemia
targets
PCSK9 mRNA
all catalysts(8)
approval · 8
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that